C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2011
06/23/2011	US20110154522 BH3 Peptides And Method Of Use Thereof
06/23/2011	US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
06/23/2011	US20110154520 Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives
06/23/2011	US20110154519 Hafnia phytase
06/23/2011	US20110154518 GENERATION OF INDUCED PLURIPOTENT STEM (iPS) CELLS
06/23/2011	US20110154516 Human factor ix variants with an extended half life
06/23/2011	US20110154515 Genetically encoded calcium sensors comprising the c-terminal lobe of troponin c and a fluorescence tag
06/23/2011	US20110154514 Polynucleotide used for releasing recombinant protein to the outside of eukaryotic cell
06/23/2011	US20110154513 Probe for visualizing neural activity
06/23/2011	US20110154511 Heparanase deficient non-human mammals
06/23/2011	US20110154510 Automated high-content live animal drug screening using c. elegans
06/23/2011	US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders
06/23/2011	US20110152502 Fluorescent protein
06/23/2011	US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof
06/23/2011	US20110152354 Bispecific Oligonucleotide for the Treatment of CNS Malignancies
06/23/2011	US20110152352 Smad proteins control drosha-mediated mirna maturation
06/23/2011	US20110152350 Compositions and Methods for Inhibiting Expression of XBP-1 Gene
06/23/2011	US20110152349 Compositions and methods for inhibiting expression of il-18 genes
06/23/2011	US20110152347 Methods and compositions for controlling efficacy of RNA silencing
06/23/2011	US20110152346 Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids
06/23/2011	US20110152345 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
06/23/2011	US20110152215 Riboswitches, methods for their use, and compositions for use with riboswitches
06/23/2011	US20110152213 Riboswitches, methods for their use, and compositions for use with riboswitches
06/23/2011	US20110152200 Methods and compositions for inhibition of bcl6 repression
06/23/2011	US20110152199 Cdca1 peptide and pharmaceutical agent comprising the same
06/23/2011	US20110152193 Inhibitors of human plasmin derived from the kunitz domains
06/23/2011	US20110152191 Natriuretic polypeptides with unique pharmacologic profiles
06/23/2011	US20110152187 Insulin-like growth factor fusion proteins
06/23/2011	US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS
06/23/2011	US20110152171 Histamine binding protein
06/23/2011	US20110152155 Subtilase variants
06/23/2011	US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof
06/23/2011	US20110151567 Recombinant Microorganism
06/23/2011	US20110151566 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto
06/23/2011	US20110151558 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
06/23/2011	US20110151557 Compositions and methods for transfection of rna and controlled stabilization of transfected rna
06/23/2011	US20110151539 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
06/23/2011	US20110151536 Thrombin activator compositions and methods of making and using the same
06/23/2011	US20110151522 Glucoamylase Variants
06/23/2011	US20110151521 cDNA SYNTHESIS IMPROVEMENTS
06/23/2011	US20110151520 Compositions and methods for cDNA synthesis
06/23/2011	US20110151518 Method for modifying chromosomes
06/23/2011	US20110151515 Production of fc-fusion polypeptides in eukaryotic algae
06/23/2011	US20110151514 Vectors, Methods, Systems and Kits for Protein Purification
06/23/2011	US20110151513 Shrna-mediated inhibition of expression of alpha-1,6-fucosyltransferase
06/23/2011	US20110151511 Rapid growing microorganisms for biotechnology applications
06/23/2011	US20110151509 Preparation of 7-dehydrocholesterol and/or the biosynthetic intermediates and/or secondary products thereof in transgenic organisms
06/23/2011	US20110151496 Methods for identifying bacterial strains that produce l-tyrosine
06/23/2011	US20110151484 hERG MUTANTS AND USES THEREOF
06/23/2011	US20110151483 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1
06/23/2011	US20110151473 Polynucleotides and Polypeptides Encoding Receptors
06/23/2011	US20110151472 Novel means for the diagnosis and therapy of ctcl
06/23/2011	US20110151471 Riboswitches, methods for their use, and compositions for use with riboswitches
06/23/2011	US20110151448 Methods and Systems for High Homologous Recombination ("HR") Targeting Efficiency
06/23/2011	US20110151447 Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
06/23/2011	US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
06/23/2011	US20110151053 Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore
06/23/2011	US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen
06/23/2011	US20110150936 Anti-tumoral cells
06/23/2011	US20110150933 Cattle vaccines
06/23/2011	US20110150930 Recombinant viral-based malaria vaccines
06/23/2011	US20110150921 Novel fusion proteins and use thereof for preparing hepatitis c vaccines
06/23/2011	US20110150920 Allergy Vaccines Containing Hybrid Polypeptides
06/23/2011	US20110150918 Treatment of microbial infections
06/23/2011	US20110150917 Small Cationic Antimicrobial Peptides
06/23/2011	US20110150915 Polyvalent vaccine
06/23/2011	US20110150913 Torque teno virus (ttv) isolates and compositions
06/23/2011	US20110150910 Methods of inducing an immune response
06/23/2011	US20110150903 Fgf-r4 receptor-specific antagonists
06/23/2011	US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho
06/23/2011	US20110150897 Influenza targets
06/23/2011	US20110150895 Antibody specifically binding to angiopoietin-2 and use thereof
06/23/2011	US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof
06/23/2011	US20110150889 Haemophilus influenzae type iv pili
06/23/2011	US20110150888 Anti-hepcidin antibodies and methods of use
06/23/2011	US20110150887 Methods and products relating to gsk3beta regulation
06/23/2011	US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis
06/23/2011	US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer
06/23/2011	US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer
06/23/2011	US20110150877 Ephrin-b receptor protein involved in carcinoma
06/23/2011	US20110150874 Fusion proteins, uses thereof and processes for producing same
06/23/2011	US20110150868 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
06/23/2011	US20110150866 Compositions and Methods for Increasing Bone Mineralization
06/23/2011	US20110150865 Antibodies to lymphotoxin-alpha
06/23/2011	US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
06/23/2011	US20110150862 Inhibitors of stim1 for the treatment of cardiovascular disorders
06/23/2011	US20110150861 Sorf constructs and multiple gene expression
06/23/2011	US20110150854 Riboswitches, methods for their use, and compositions for use with riboswitches
06/23/2011	US20110150852 Novel Strain of Lactobacillus Paracasei Subspecies Paracasei Having Antimicrobial and Immunomodulatory Properties
06/23/2011	US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules
06/23/2011	US20110150842 Derivation of Embryonic Stem Cells
06/23/2011	US20110150841 Secretion System and Methods for its Use
06/23/2011	US20110150838 Lactobacillus paracasei strain lt12 as immunity regulatory agent
06/23/2011	US20110150832 Furin-knockdown bi-functional rna
06/23/2011	US20110150828 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof
06/23/2011	US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
06/23/2011	US20110150768 Compositions and methods for delivering inhibitory oligonucleotides
06/23/2011	US20110150760 PRLR-Specific Antibody and Uses Thereof
06/23/2011	US20110150759 Monoclonal antibody 175 tageting the egf receptor and derivatives and uses thereof
06/23/2011	CA2784784A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant

1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 4023